ProRx LLC recalls Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-0
Recalled September 11, 2024 · FDA recall D-0650-2024 · ProRx
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
2,490 vials
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility
Product
Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01
Manufacturer(s)
ProRx LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →